{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T06:41:37Z","timestamp":1791873697475,"version":"4.3.4"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-20650-1","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T09:30:00Z","timestamp":1761039000000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Tacrolimus modulates the PI3K AKT mTOR pathway in retinal epithelial cells under inflammatory stress"],"prefix":"10.1038","volume":"15","author":[{"given":"Aleksandra","family":"Kie\u0142basi\u0144ska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beniamin Oskar","family":"Grabarek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominika","family":"Janiszewska-Bil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martyna","family":"Machaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzanna","family":"Lelek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita Lyssek","family":"Boro\u0144","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Janusz","family":"Koss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Waszak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Krysik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"key":"20650_CR1","doi-asserted-by":"publisher","unstructured":"Lakkaraju, A. et al. The cell biology of the retinal pigment epithelium. Prog. Retin. Eye Res. 78, 100846. https:\/\/doi.org\/10.1016\/j.preteyeres.2020.100846 (2020).","DOI":"10.1016\/j.preteyeres.2020.100846"},{"key":"20650_CR2","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3390\/biomedicines11020310","volume":"11","author":"S Gupta","year":"2023","unstructured":"Gupta, S. et al. Retinal pigment epithelium cell development: extrapolating basic biology to stem cell research. Biomedicines 11, 310. https:\/\/doi.org\/10.3390\/biomedicines11020310 (2023).","journal-title":"Biomedicines"},{"key":"20650_CR3","doi-asserted-by":"publisher","first-page":"727870","DOI":"10.3389\/fphar.2021.727870","volume":"12","author":"S Yang","year":"2021","unstructured":"Yang, S., Zhou, J. & Li, D. Functions and diseases of the retinal pigment epithelium. Front. Pharmacol. 12, 727870 (2021).","journal-title":"Front. Pharmacol."},{"key":"20650_CR4","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s00417-023-06264-1","volume":"262","author":"L Ferro Desideri","year":"2024","unstructured":"Ferro Desideri, L., Artemiev, D., Zandi, S., Zinkernagel, M. S. & Anguita, R. Proliferative vitreoretinopathy: An update on the current and emerging treatment options. Graefes Arch. Clin. Exp. Ophthalmol. 262, 679\u2013687. https:\/\/doi.org\/10.1007\/s00417-023-06264-1 (2024).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"20650_CR5","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1136\/bjo-2023-324417","volume":"108","author":"A Assi","year":"2024","unstructured":"Assi, A. & Charteris, D. Proliferative vitreoretinopathy: A revised concept of retinal injury and response. Br. J. Ophthalmol. 108, 1621\u20131626. https:\/\/doi.org\/10.1136\/bjo-2023-324417 (2024).","journal-title":"Br. J. Ophthalmol."},{"key":"20650_CR6","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.3390\/ijms26031025","volume":"26","author":"N Harju","year":"2025","unstructured":"Harju, N., Kauppinen, A. & Loukovaara, S. Fibrotic changes in rhegmatogenous retinal detachment. Int. J. Mol. Sci. 26, 1025. https:\/\/doi.org\/10.3390\/ijms26031025 (2025).","journal-title":"Int. J. Mol. Sci."},{"key":"20650_CR7","doi-asserted-by":"publisher","first-page":"916719","DOI":"10.3389\/fncel.2022.916719","volume":"16","author":"M Szczepan","year":"2022","unstructured":"Szczepan, M., Llori\u00e1n-Salvador, M., Chen, M. & Xu, H. Immune cells in subretinal wound healing and fibrosis. Front. Cell. Neurosci. 16, 916719. https:\/\/doi.org\/10.3389\/fncel.2022.916719 (2022).","journal-title":"Front. Cell. Neurosci."},{"key":"20650_CR8","doi-asserted-by":"crossref","unstructured":"Zhu, C., Cheng, Y., Tang, Y. & Wu, H. Changes of aqueous humor cytokine profiles of patients with high intraocular pressure after PPV for retinal detachment (2023).","DOI":"10.21203\/rs.3.rs-3288564\/v1"},{"key":"20650_CR9","doi-asserted-by":"publisher","first-page":"1331800","DOI":"10.3389\/fphar.2024.1331800","volume":"15","author":"M Wang","year":"2024","unstructured":"Wang, M., Zhou, J., Niu, Q. & Wang, H. Mechanism of tacrolimus in the treatment of lupus nephritis. Front. Pharmacol. 15, 1331800 (2024).","journal-title":"Front. Pharmacol."},{"key":"20650_CR10","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.jconrel.2021.03.035","volume":"333","author":"L Rebibo","year":"2021","unstructured":"Rebibo, L. et al. Topical tacrolimus nanocapsules eye drops for therapeutic effect enhancement in both anterior and posterior ocular inflammation models. J. Control Release 333, 283\u2013297. https:\/\/doi.org\/10.1016\/j.jconrel.2021.03.035 (2021).","journal-title":"J. Control Release"},{"key":"20650_CR11","doi-asserted-by":"publisher","unstructured":"Aa, A., Ha, O., Fem, F. H. & Amm, A. Impact of the ACE2 activator Xanthenone on tacrolimus nephrotoxicity: Modulation of uric acid\/ERK\/p38 MAPK and Nrf2\/SOD3\/GCLC signaling pathways. Life Sci.. https:\/\/doi.org\/10.1016\/j.lfs.2021.120154 (2022).","DOI":"10.1016\/j.lfs.2021.120154"},{"key":"20650_CR12","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.semcancer.2021.06.019","volume":"85","author":"L Yu","year":"2022","unstructured":"Yu, L., Wei, J. & Liu, P. Attacking the PI3K\/Akt\/mTOR signaling pathway for targeted therapeutic treatment in human cancer. Sem. Cancer Biol. 85, 69\u201394. https:\/\/doi.org\/10.1016\/j.semcancer.2021.06.019 (2022).","journal-title":"Sem. Cancer Biol."},{"key":"20650_CR13","doi-asserted-by":"publisher","first-page":"117526","DOI":"10.1016\/j.biopha.2024.117526","volume":"180","author":"X Chen","year":"2024","unstructured":"Chen, X., Hu, K., Zhang, Y., He, S-M. & Wang, D-D. Targeting CXCR2 ameliorated tacrolimus-induced nephrotoxicity by alleviating overactivation of PI3K\/AKT\/mTOR pathway and calcium overload. Biomed. Pharmacother. 180, 117526. https:\/\/doi.org\/10.1016\/j.biopha.2024.117526 (2024).","journal-title":"Biomed. Pharmacother"},{"key":"20650_CR14","doi-asserted-by":"publisher","first-page":"16033","DOI":"10.1021\/acs.jmedchem.2c01070","volume":"65","author":"J Huang","year":"2022","unstructured":"Huang, J. et al. Targeting the PI3K\/AKT\/mTOR signaling pathway in the treatment of human diseases: Current status, trends, and solutions. J. Med. Chem. 65, 16033\u201316061. https:\/\/doi.org\/10.1021\/acs.jmedchem.2c01070 (2022).","journal-title":"J. Med. Chem."},{"key":"20650_CR15","doi-asserted-by":"publisher","first-page":"10260","DOI":"10.3390\/ijms221910260","volume":"22","author":"C Stefani","year":"2021","unstructured":"Stefani, C. et al. PI3K\/AKT\/mTOR and MAPK signaling pathways in colorectal cancer pathogenesis: Where are we now? Int. J. Mol. Sci. 22, 10260. https:\/\/doi.org\/10.3390\/ijms221910260 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"20650_CR16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3892\/mi.2024.206","volume":"5","author":"M Amoushahi","year":"2025","unstructured":"Amoushahi, M., J\u00f8rgensen, P. H., Kjeldgaard, A. B., Padi, E. & Fossum, M. MicroRNAs and hypospadias: A systematic review. Med. Int. 5, 7. https:\/\/doi.org\/10.3892\/mi.2024.206 (2025).","journal-title":"Med. Int. (Lond)"},{"key":"20650_CR17","doi-asserted-by":"publisher","first-page":"5402","DOI":"10.3390\/ijms26115402","volume":"26","author":"A Kie\u0142basi\u0144ska","year":"2025","unstructured":"Kie\u0142basi\u0144ska, A. et al. Tacrolimus modulates TGF-\u03b2 Signaling-Related genes and MicroRNAs in human retinal pigment epithelial cells activated by lipopolysaccharide. Int. J. Mol. Sci. 26, 5402. https:\/\/doi.org\/10.3390\/ijms26115402 (2025).","journal-title":"Int. J. Mol. Sci."},{"key":"20650_CR18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cbpa.2019.01.024","volume":"51","author":"Q Yao","year":"2019","unstructured":"Yao, Q., Chen, Y. & Zhou, X. The roles of MicroRNAs in epigenetic regulation. Curr. Opin. Chem. Biol. 51, 11\u201317. https:\/\/doi.org\/10.1016\/j.cbpa.2019.01.024 (2019).","journal-title":"Curr. Opin. Chem. Biol."},{"key":"20650_CR19","unstructured":"MicroRNAs\u2019 role in the environment-related non-communicable diseases and link to multidrug resistance, regulation, or alteration - PubMed n.d. https:\/\/pubmed.ncbi.nlm.nih.gov\/34046834\/. Accessed 17 June 2025."},{"key":"20650_CR20","unstructured":"Artesunate inhibits the development. of PVR by suppressing the TGF-\u03b2\/Smad signaling pathway - PubMed n.d.. https:\/\/pubmed.ncbi.nlm.nih.gov\/34822854\/. Accessed 17 June 2025."},{"key":"20650_CR21","doi-asserted-by":"publisher","first-page":"8586711","DOI":"10.1155\/mi\/8586711","volume":"2025","author":"A Kie\u0142basi\u0144ska","year":"2025","unstructured":"Kie\u0142basi\u0144ska, A. et al. Evaluation of gene expression and the regulatory role of MicroRNAs related to the Mitogen-Activated protein kinase signaling pathway in human retinal pigment epithelial cells treated with lipopolysaccharide A and tacrolimus. Mediators Inflamm. 2025, 8586711. https:\/\/doi.org\/10.1155\/mi\/8586711 (2025).","journal-title":"Mediators Inflamm."},{"key":"20650_CR22","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.pharep.2016.04.020","volume":"68","author":"M Kimsa","year":"2016","unstructured":"Kimsa, M. et al. Transforming growth factor \u03b2-related genes in human retinal pigment epithelial cells after tacrolimus treatment. Pharmacol. Rep. 68, 969\u2013974. https:\/\/doi.org\/10.1016\/j.pharep.2016.04.020 (2016).","journal-title":"Pharmacol. Rep."},{"key":"20650_CR23","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1007\/s10753-020-01377-9","volume":"44","author":"R Qiu","year":"2021","unstructured":"Qiu, R. et al. The protective effects of VVN001 on LPS-Induced inflammatory responses in human RPE cells and in a mouse model of EIU. Inflammation 44, 780\u2013794. https:\/\/doi.org\/10.1007\/s10753-020-01377-9 (2021).","journal-title":"Inflammation"},{"key":"20650_CR24","doi-asserted-by":"publisher","first-page":"8387","DOI":"10.3390\/ijms22168387","volume":"22","author":"A Klettner","year":"2021","unstructured":"Klettner, A. & Roider, J. Retinal pigment epithelium expressed toll-like receptors and their potential role in age-related macular degeneration. Int. J. Mol. Sci. 22, 8387 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"20650_CR25","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Kawashima, M. & Ishiguro-Watanabe, M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 51, D587\u2013D592. https:\/\/doi.org\/10.1093\/nar\/gkac963 (2023).","journal-title":"Nucleic Acids Res."},{"key":"20650_CR26","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: Biological systems database as a model of the real world. Nucleic Acids Res. 53, D672\u2013D677. https:\/\/doi.org\/10.1093\/nar\/gkae909 (2025).","journal-title":"Nucleic Acids Res."},{"key":"20650_CR27","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330. https:\/\/doi.org\/10.1093\/nar\/28.1.27 (2000).","journal-title":"Nucleic Acids Res."},{"key":"20650_CR28","doi-asserted-by":"publisher","first-page":"e05005","DOI":"10.7554\/eLife.05005","volume":"4","author":"V Agarwal","year":"2015","unstructured":"Agarwal, V., Bell, G. W., Nam, J-W. & Bartel, D. P. Predicting effective MicroRNA target sites in mammalian mRNAs. eLife 4, e05005. https:\/\/doi.org\/10.7554\/eLife.05005 (2015).","journal-title":"eLife"},{"key":"20650_CR29","doi-asserted-by":"publisher","first-page":"D127","DOI":"10.1093\/nar\/gkz757","volume":"48","author":"Y Chen","year":"2020","unstructured":"Chen, Y. & Wang, X. MiRDB: An online database for prediction of functional MicroRNA targets. Nucleic Acids Res. 48, D127\u2013D131. https:\/\/doi.org\/10.1093\/nar\/gkz757 (2020).","journal-title":"Nucleic Acids Res."},{"key":"20650_CR30","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13059-019-1629-z","volume":"20","author":"W Liu","year":"2019","unstructured":"Liu, W. & Wang, X. Prediction of functional MicroRNA targets by integrative modeling of MicroRNA binding and target expression data. Genome Biol. 20, 18. https:\/\/doi.org\/10.1186\/s13059-019-1629-z (2019).","journal-title":"Genome Biol."},{"key":"20650_CR31","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk, D. et al. The STRING database in 2023: Protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 51, D638\u2013D646. https:\/\/doi.org\/10.1093\/nar\/gkac1000 (2023).","journal-title":"Nucleic Acids Res."},{"key":"20650_CR32","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12974-024-03055-1","volume":"21","author":"A Brandli","year":"2024","unstructured":"Brandli, A., Vessey, K. A. & Fletcher, E. L. The contribution of pattern recognition receptor signalling in the development of age related macular degeneration: The role of toll-like-receptors and the NLRP3-inflammasome. J. Neuroinflamm. 21, 64. https:\/\/doi.org\/10.1186\/s12974-024-03055-1 (2024).","journal-title":"J. Neuroinflammation"},{"key":"20650_CR33","doi-asserted-by":"publisher","first-page":"3687","DOI":"10.3892\/mmr.2020.11453","volume":"22","author":"Y Ren","year":"2020","unstructured":"Ren, Y. et al. Effects of tacrolimus on the TGF\u2013\u03b21\/SMAD signaling pathway in paraquat\u2013exposed rat alveolar type II epithelial cells. Mol. Med. Rep. 22, 3687\u20133694. https:\/\/doi.org\/10.3892\/mmr.2020.11453 (2020).","journal-title":"Mol. Med. Rep."},{"key":"20650_CR34","doi-asserted-by":"publisher","first-page":"e70028","DOI":"10.1002\/iid3.70028","volume":"12","author":"AY Binsaleh","year":"2024","unstructured":"Binsaleh, A. Y. et al. Tacrolimus versus hydrocortisone in management of atopic dermatitis in children, a randomized controlled double-blind study: New insights on TARC, CTACK, TSLP, and E-selectin. Immun. Inflamm. Dis. 12, e70028. https:\/\/doi.org\/10.1002\/iid3.70028 (2024).","journal-title":"Immun. Inflamm. Dis."},{"key":"20650_CR35","doi-asserted-by":"publisher","first-page":"4025","DOI":"10.1038\/s41467-024-47634-5","volume":"15","author":"C Lee","year":"2024","unstructured":"Lee, C. et al. Oxidative photocatalysis on membranes triggers non-canonical pyroptosis. Nat. Commun. 15, 4025. https:\/\/doi.org\/10.1038\/s41467-024-47634-5 (2024).","journal-title":"Nat. Commun."},{"key":"20650_CR36","doi-asserted-by":"publisher","first-page":"100969","DOI":"10.1016\/j.preteyeres.2021.100969","volume":"85","author":"SM George","year":"2021","unstructured":"George, S. M., Lu, F., Rao, M., Leach, L. L. & Gross, J. M. The retinal pigment epithelium: Development, injury responses, and regenerative potential in mammalian and non-mammalian systems. Prog. Retin. Eye Res. 85, 100969 (2021).","journal-title":"Prog. Retin. Eye Res."},{"key":"20650_CR37","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1167\/tvst.9.3.23","volume":"9","author":"R Chaudhary","year":"2020","unstructured":"Chaudhary, R. et al. Inflammatory and fibrogenic factors in proliferative vitreoretinopathy development. Transl. Vis. Sci. Technol. 9, 23. https:\/\/doi.org\/10.1167\/tvst.9.3.23 (2020).","journal-title":"Transl Vis. Sci. Technol."},{"key":"20650_CR38","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s42485-024-00140-0","volume":"15","author":"S Sharma","year":"2024","unstructured":"Sharma, S. et al. A simulacrum of proliferative vitreoretinopathy (PVR): Development and proteomics-based validation of an in vitro model. J. Proteins Proteom. 15, 105\u2013118. https:\/\/doi.org\/10.1007\/s42485-024-00140-0 (2024).","journal-title":"J. Proteins Proteom."},{"key":"20650_CR39","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1007\/s10792-020-01325-4","volume":"40","author":"Y Dai","year":"2020","unstructured":"Dai, Y., Dai, C. & Sun, T. Inflammatory mediators of proliferative vitreoretinopathy: Hypothesis and review. Int. Ophthalmol. 40, 1587\u20131601. https:\/\/doi.org\/10.1007\/s10792-020-01325-4 (2020).","journal-title":"Int. Ophthalmol."},{"key":"20650_CR40","first-page":"91","volume":"9","author":"E Tsotridou","year":"2020","unstructured":"Tsotridou, E. et al. A review of last decade developments on epiretinal membrane pathogenesis. Med. Hypothesis Discov. Innov. Ophthalmol. 9, 91\u2013110 (2020).","journal-title":"Med. Hypothesis Discov Innov. Ophthalmol."},{"key":"20650_CR41","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/978-981-97-4283-7_3","volume-title":"A Short Guide To Clinical Pharmacokinetics","author":"K Manubolu","year":"2024","unstructured":"Manubolu, K. Pharmaceutical drug interactions. In A Short Guide To Clinical Pharmacokinetics 37\u201352 (eds Manubolu, K., Peeriga, R. & Chandrasekhar, K. B.) (Springer, 2024). https:\/\/doi.org\/10.1007\/978-981-97-4283-7_3."},{"key":"20650_CR42","doi-asserted-by":"publisher","first-page":"263","DOI":"10.21037\/atm.2020.03.86","volume":"8","author":"X Li","year":"2020","unstructured":"Li, X., Zhao, M. & He, S. RPE epithelial-mesenchymal transition plays a critical role in the pathogenesis of proliferative vitreoretinopathy. Ann. Transl. Med. 8, 263 (2020).","journal-title":"Annals Translational Med."},{"key":"20650_CR43","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s13287-025-04226-4","volume":"16","author":"J Huang","year":"2025","unstructured":"Huang, J. et al. Mesenchymal cell-derived exosomes and miR-29a-3p mitigate renal fibrosis and vascular rarefaction after renal ischemia reperfusion injury. Stem Cell. Res. Ther. 16, 135. https:\/\/doi.org\/10.1186\/s13287-025-04226-4 (2025).","journal-title":"Stem Cell. Res. Ther."},{"key":"20650_CR44","doi-asserted-by":"publisher","unstructured":"Han, S., Wang, Z., Liu, J., David Wang, H-M. & Yuan, Q. Corrigendum to miR-29a-3p-dependent COL3A1 and COL5A1 expression reduction assists sulforaphane to inhibit gastric cancer progression [Biochem. Pharmacol. 188 (2021) 114539]. Biochem. Pharmacol. 208, 115389. https:\/\/doi.org\/10.1016\/j.bcp.2022.115389 (2023).","DOI":"10.1016\/j.bcp.2022.115389"},{"key":"20650_CR45","doi-asserted-by":"publisher","first-page":"1001453","DOI":"10.3389\/fcell.2022.1001453","volume":"10","author":"Y Tian","year":"2022","unstructured":"Tian, Y. et al. Immunosuppressants tacrolimus and sirolimus revert the cardiac antifibrotic properties of p38-MAPK inhibition in 3D-multicellular human iPSC-heart organoids. Front. Cell. Dev. Biol. 10, 1001453. https:\/\/doi.org\/10.3389\/fcell.2022.1001453 (2022).","journal-title":"Front. Cell. Dev. Biol."},{"key":"20650_CR46","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.2174\/1389557523666230328125031","volume":"23","author":"M Wang","year":"2023","unstructured":"Wang, M. et al. The role of MiR-29 in the mechanism of fibrosis. Mini Rev. Med. Chem. 23, 1846\u20131858. https:\/\/doi.org\/10.2174\/1389557523666230328125031 (2023).","journal-title":"Mini Rev. Med. Chem."},{"key":"20650_CR47","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1165\/rcmb.2010-0323OC","volume":"45","author":"L Cushing","year":"2011","unstructured":"Cushing, L. et al. miR-29 is a major regulator of genes associated with pulmonary fibrosis. Am. J. Respir Cell. Mol. Biol. 45, 287\u2013294. https:\/\/doi.org\/10.1165\/rcmb.2010-0323OC (2011).","journal-title":"Am. J. Respir Cell. Mol. Biol."},{"key":"20650_CR48","doi-asserted-by":"publisher","first-page":"9696","DOI":"10.3390\/ijms22189696","volume":"22","author":"N Meyer","year":"2021","unstructured":"Meyer, N., Brodowski, L., von Kaisenberg, C., Schr\u00f6der-Heurich, B. & von Versen-H\u00f6ynck, F. Cyclosporine A and tacrolimus induce functional impairment and inflammatory reactions in endothelial progenitor cells. Int. J. Mol. Sci. 22, 9696. https:\/\/doi.org\/10.3390\/ijms22189696 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"20650_CR49","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s13346-019-00666-7","volume":"10","author":"MH Nabavi","year":"2020","unstructured":"Nabavi, M. H. et al. A collagen-based hydrogel containing tacrolimus for bone tissue engineering. Drug Deliv. Transl. Res. 10, 108\u2013121. https:\/\/doi.org\/10.1007\/s13346-019-00666-7 (2020).","journal-title":"Drug Deliv Transl Res."},{"key":"20650_CR50","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.3892\/ijmm.2019.4368","volume":"44","author":"D Wang","year":"2019","unstructured":"Wang, D., Chen, X., Fu, M., Xu, H. & Li, Z. Tacrolimus increases the expression level of the chemokine receptor CXCR2 to promote renal fibrosis progression. Int. J. Mol. Med. 44, 2181\u20132188. https:\/\/doi.org\/10.3892\/ijmm.2019.4368 (2019).","journal-title":"Int. J. Mol. Med."},{"key":"20650_CR51","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/cbin.10861","volume":"42","author":"W-S Lee","year":"2018","unstructured":"Lee, W-S. et al. Tacrolimus regulates Endoplasmic reticulum stress-mediated osteoclastogenesis and inflammation: In vitro and collagen-induced arthritis mouse model. Cell. Biol. Int. 42, 393\u2013402. https:\/\/doi.org\/10.1002\/cbin.10861 (2018).","journal-title":"Cell. Biol. Int."},{"key":"20650_CR52","doi-asserted-by":"publisher","first-page":"1389329","DOI":"10.3389\/fmed.2024.1389329","volume":"11","author":"E Shamsan","year":"2024","unstructured":"Shamsan, E. et al. The role of PI3k\/AKT signaling pathway in attenuating liver fibrosis: A comprehensive review. Front. Med. 11, 1389329. https:\/\/doi.org\/10.3389\/fmed.2024.1389329 (2024).","journal-title":"Front. Med. (Lausanne)"},{"key":"20650_CR53","doi-asserted-by":"publisher","first-page":"16142","DOI":"10.3390\/ijms232416142","volume":"23","author":"JJ Yu","year":"2022","unstructured":"Yu, J. J. & Goncharova, E. A. mTOR signaling network in cell biology and human disease. Int. J. Mol. Sci. 23, 16142. https:\/\/doi.org\/10.3390\/ijms232416142 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"20650_CR54","doi-asserted-by":"publisher","first-page":"658","DOI":"10.3892\/mmr.2021.12297","volume":"24","author":"L Tong","year":"2021","unstructured":"Tong, L. et al. Tacrolimus inhibits insulin release and promotes apoptosis of Min6 cells through the Inhibition of the PI3K\/Akt\/mTOR pathway. Mol. Med. Rep. 24, 658. https:\/\/doi.org\/10.3892\/mmr.2021.12297 (2021).","journal-title":"Mol. Med. Rep."},{"key":"20650_CR55","doi-asserted-by":"publisher","first-page":"e13435","DOI":"10.1111\/cpr.13435","volume":"56","author":"Q Tang","year":"2023","unstructured":"Tang, Q. et al. TGF-\u03b2-induced PI3K\/AKT\/mTOR pathway controls myofibroblast differentiation and secretory phenotype of valvular interstitial cells through the modulation of cellular senescence in a naturally occurring in vitro canine model of myxomatous mitral valve disease. Cell. Prolif. 56, e13435. https:\/\/doi.org\/10.1111\/cpr.13435 (2023).","journal-title":"Cell. Prolif."},{"key":"20650_CR56","doi-asserted-by":"publisher","first-page":"120150","DOI":"10.1016\/j.lfs.2021.120150","volume":"288","author":"T Shigematsu","year":"2022","unstructured":"Shigematsu, T. et al. The mTOR inhibitor everolimus attenuates tacrolimus-induced renal interstitial fibrosis in rats. Life Sci. 288, 120150. https:\/\/doi.org\/10.1016\/j.lfs.2021.120150 (2022).","journal-title":"Life Sci."},{"key":"20650_CR57","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1038\/s41416-024-02597-8","volume":"130","author":"D Moldvai","year":"2024","unstructured":"Moldvai, D. et al. Tumorigenic role of tacrolimus through mTORC1\/C2 activation in post-transplant renal cell carcinomas. Br. J. Cancer 130, 1119\u20131130. https:\/\/doi.org\/10.1038\/s41416-024-02597-8 (2024).","journal-title":"Br. J. Cancer"},{"key":"20650_CR58","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1080\/15548627.2020.1713640","volume":"16","author":"M Bernard","year":"2020","unstructured":"Bernard, M. & H\u00e9bert M-J. Autophagy drives fibroblast senescence through MTORC2 regulation. Autophagy 16, 2004\u20132016. https:\/\/doi.org\/10.1080\/15548627.2020.1713640 (2020).","journal-title":"Autophagy"},{"key":"20650_CR59","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.3390\/cells8091075","volume":"8","author":"X Wei","year":"2019","unstructured":"Wei, X., Luo, L. & Chen, J. Roles of mTOR signaling in tissue regeneration. Cells 8, 1075. https:\/\/doi.org\/10.3390\/cells8091075 (2019).","journal-title":"Cells"},{"key":"20650_CR60","doi-asserted-by":"publisher","first-page":"7083","DOI":"10.1073\/pnas.1620835114","volume":"114","author":"G Whitehouse","year":"2017","unstructured":"Whitehouse, G. et al. IL-2 therapy restores regulatory T-cell dysfunction induced by calcineurin inhibitors. Proc. Natl. Acad. Sci. U. S. A. 114, 7083\u20137088. https:\/\/doi.org\/10.1073\/pnas.1620835114 (2017).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"20650_CR61","doi-asserted-by":"publisher","unstructured":"Zakerkish, F., Soriano, M. J., Novella-Mestre, E., Br\u00e4nnstr\u00f6m, M. & D\u00edaz-Garc\u00eda, C. Differential effects of the immunosuppressive calcineurin inhibitors cyclosporine-A and tacrolimus on ovulation in a murine model. Hum. Reprod. Open 2021, hoab012. https:\/\/doi.org\/10.1093\/hropen\/hoab012 (2021).","DOI":"10.1093\/hropen\/hoab012"},{"key":"20650_CR62","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/dgd.12630","volume":"61","author":"R Jing","year":"2019","unstructured":"Jing, R. et al. Interleukin-2 induces extracellular matrix synthesis and TGF-\u03b22 expression in retinal pigment epithelial cells. Dev. Growth Differ. 61, 410\u2013418. https:\/\/doi.org\/10.1111\/dgd.12630 (2019).","journal-title":"Dev. Growth Differ."},{"key":"20650_CR63","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.exer.2018.07.017","volume":"177","author":"A Voisin","year":"2018","unstructured":"Voisin, A. et al. hRPE cells derived from induced pluripotent stem cells are more sensitive to oxidative stress than ARPE-19 cells. Exp. Eye Res. 177, 76\u201386. https:\/\/doi.org\/10.1016\/j.exer.2018.07.017 (2018).","journal-title":"Exp. Eye Res."},{"key":"20650_CR64","doi-asserted-by":"publisher","first-page":"1326066","DOI":"10.3389\/fimmu.2024.1326066","volume":"15","author":"Y Nasa","year":"2024","unstructured":"Nasa, Y. et al. Concomitant use of interleukin-2 and tacrolimus suppresses follicular helper T cell proportion and exerts therapeutic effect against lupus nephritis in systemic lupus erythematosus-like chronic graft versus host disease. Front. Immunol. 15, 1326066. https:\/\/doi.org\/10.3389\/fimmu.2024.1326066 (2024).","journal-title":"Front. Immunol."},{"key":"20650_CR65","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.1111\/ajt.17181","volume":"22","author":"T Hirai","year":"2022","unstructured":"Hirai, T. et al. IL-2 receptor engineering enhances regulatory T cell function suppressed by calcineurin inhibitor. Am. J. Transpl. 22, 3061\u20133068. https:\/\/doi.org\/10.1111\/ajt.17181 (2022).","journal-title":"Am. J. Transpl."},{"key":"20650_CR66","doi-asserted-by":"publisher","first-page":"111999","DOI":"10.1016\/j.intimp.2024.111999","volume":"132","author":"B Liu","year":"2024","unstructured":"Liu, B. et al. Tacrolimus alleviates pulmonary fibrosis progression through inhibiting the activation and interaction of ILC2 and monocytes. Int. Immunopharmacol. 132, 111999. https:\/\/doi.org\/10.1016\/j.intimp.2024.111999 (2024).","journal-title":"Int. Immunopharmacol."},{"key":"20650_CR67","doi-asserted-by":"publisher","first-page":"311","DOI":"10.5125\/jkaoms.2023.49.6.311","volume":"49","author":"H Lee","year":"2023","unstructured":"Lee, H., Myoung, H. & Kim, S. M. Review of two immunosuppressants: Tacrolimus and cyclosporine. J. Korean Assoc. Oral Maxillofac. Surg. 49, 311\u2013323 (2023).","journal-title":"J. Korean Association Oral Maxillofacial Surg."},{"key":"20650_CR68","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.preteyeres.2017.03.002","volume":"60","author":"S Datta","year":"2017","unstructured":"Datta, S., Cano, M., Ebrahimi, K., Wang, L. & Handa, J. T. The impact of oxidative stress and inflammation on RPE degeneration in non-neovascular AMD. Prog. Retin. Eye Res. 60, 201\u2013218. https:\/\/doi.org\/10.1016\/j.preteyeres.2017.03.002 (2017).","journal-title":"Prog Retin Eye Res."},{"key":"20650_CR69","first-page":"517","volume":"26","author":"X Chen","year":"2020","unstructured":"Chen, X., Yang, W., Deng, X., Ye, S. & Xiao, W. Interleukin-6 promotes proliferative vitreoretinopathy by inducing epithelial-mesenchymal transition via the JAK1\/STAT3 signaling pathway. Mol. Vis. 26, 517\u2013529 (2020).","journal-title":"Mol. Vis."},{"key":"20650_CR70","doi-asserted-by":"publisher","first-page":"109556","DOI":"10.1016\/j.exer.2023.109556","volume":"233","author":"R Xiao","year":"2023","unstructured":"Xiao, R., Lei, C., Zhang, Y. & Zhang, M. Interleukin-6 in retinal diseases: From pathogenesis to therapy. Exp. Eye Res. 233, 109556. https:\/\/doi.org\/10.1016\/j.exer.2023.109556 (2023).","journal-title":"Exp. Eye Res."},{"key":"20650_CR71","doi-asserted-by":"publisher","first-page":"4271","DOI":"10.3390\/ijms21124271","volume":"21","author":"DY Shu","year":"2020","unstructured":"Shu, D. Y., Butcher, E. & Saint-Geniez, M. EMT and endmt: emerging roles in age-related macular degeneration. Int. J. Mol. Sci. 21, 4271. https:\/\/doi.org\/10.3390\/ijms21124271 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"20650_CR72","doi-asserted-by":"publisher","first-page":"588050","DOI":"10.3389\/fcell.2020.588050","volume":"8","author":"S Wang","year":"2020","unstructured":"Wang, S. et al. Reversed senescence of retinal pigment epithelial cell by coculture with embryonic stem cell via the TGF\u03b2 and PI3K pathways. Front. Cell. Dev. Biol. 8, 588050. https:\/\/doi.org\/10.3389\/fcell.2020.588050 (2020).","journal-title":"Front. Cell. Dev. Biol."},{"key":"20650_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/mmr.2021.12028","volume":"23","author":"Y Wang","year":"2021","unstructured":"Wang, Y. et al. Connective tissue growth factor promotes retinal pigment epithelium mesenchymal transition via the PI3K\/AKT signaling pathway. Mol. Med. Rep. 23, 1\u201313 (2021).","journal-title":"Mol. Med. Rep."},{"key":"20650_CR74","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/cbin.11797","volume":"46","author":"R Hayat","year":"2022","unstructured":"Hayat, R., Manzoor, M. & Hussain, A. Wnt signaling pathway: A comprehensive review. Cell. Biol. Int. 46, 863\u2013877. https:\/\/doi.org\/10.1002\/cbin.11797 (2022).","journal-title":"Cell. Biol. Int."},{"key":"20650_CR75","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.immuni.2024.03.004","volume":"57","author":"T Kawai","year":"2024","unstructured":"Kawai, T., Ikegawa, M., Ori, D. & Akira, S. Decoding Toll-like receptors: Recent insights and perspectives in innate immunity. Immunity 57, 649\u2013673. https:\/\/doi.org\/10.1016\/j.immuni.2024.03.004 (2024).","journal-title":"Immunity"},{"key":"20650_CR76","doi-asserted-by":"publisher","first-page":"e202400780","DOI":"10.1002\/cmdc.202400780","volume":"20","author":"S De Chiara","year":"2025","unstructured":"De Chiara, S. et al. Beyond the toll-like receptor 4. Structure-dependent lipopolysaccharide recognition systems: How far are we? ChemMedChem 20, e202400780. https:\/\/doi.org\/10.1002\/cmdc.202400780 (2025).","journal-title":"ChemMedChem"},{"key":"20650_CR77","doi-asserted-by":"publisher","first-page":"e1511","DOI":"10.1097\/TXD.0000000000001511","volume":"9","author":"I Mahaparn","year":"2023","unstructured":"Mahaparn, I. et al. The association of tacrolimus formulation on cerebral blood flow and cognitive function. Transpl. Direct 9, e1511. https:\/\/doi.org\/10.1097\/TXD.0000000000001511 (2023).","journal-title":"Transpl. Direct"},{"key":"20650_CR78","doi-asserted-by":"publisher","first-page":"317","DOI":"10.31083\/j.fbl2811317","volume":"28","author":"A Mehjabin","year":"2023","unstructured":"Mehjabin, A. et al. MicroRNA in fibrotic disorders: A potential target for future therapeutics. Front. Biosci. 28, 317. https:\/\/doi.org\/10.31083\/j.fbl2811317 (2023).","journal-title":"Front. Biosci. (Landmark Ed)"},{"key":"20650_CR79","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1177\/15353702221108379","volume":"247","author":"Y Wang","year":"2022","unstructured":"Wang, Y. et al. MiR-22-3p and miR-29a-3p synergistically inhibit hepatic stellate cell activation by targeting AKT3. Exp. Biol. Med. 247, 1712\u20131731. https:\/\/doi.org\/10.1177\/15353702221108379 (2022).","journal-title":"Exp. Biol. Med. (Maywood)"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20650-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20650-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20650-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T22:02:18Z","timestamp":1761429738000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20650-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["20650"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-20650-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,21]]},"assertion":[{"value":"1 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"36752"}}